| 1 | % | - | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1 | ppm | - | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 1 | ppm | - | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 2 | ppm | - | inhalation | rat | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| 10 | mg/kg bw/day | - | dermal | - | UnifiedCodex:SCCS_SHADOW:beta.noael_studies |
| =0.540348 | mg/m3 | BMCL (05) | inhalation | Human | ToxValDB_Cal_OEHHA_REL_derivations |
| 5.14 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 5.2 | ug/mL | CD54, EC200 | Dermal | - | NTP_ICE_skin_sensitization |
| 0.634 | ug/mL | CD86, EC120 | Dermal | - | NTP_ICE_skin_sensitization |
| 1.6 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 4.3 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 5.74 | ug/mL | CD86, EC150 | Dermal | - | NTP_ICE_skin_sensitization |
| 5.8 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| 23.3 | ug/mL | CV75 | Dermal | - | NTP_ICE_skin_sensitization |
| SQE40 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQE40 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQE40 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQE40 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| SQEcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| 0.1285 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.4116 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.9768 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.202 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2.359 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.0925 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.1028 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.222 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.4625 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| =0.375 | mg/m3 | DNEL local | inhalation | Human | ToxValDB_GESTIS_DNEL |
| =9 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 30.5 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 36.6 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 36.7 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 37.3 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 40.6 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 44.2 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 44.7 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 48.6 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 49.6 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 51.4 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 54.8 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 60.4 | % | Depletion Cys | Dermal | - | NTP_ICE_skin_sensitization |
| 0.3 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 1.3 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 1.8 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 2 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |
| 2.3 | % | Depletion Lys | Dermal | - | NTP_ICE_skin_sensitization |